SOP for use of Lumasiran (Oxlumo®) for the treatment of Primary Hyperoxaluria type 1 (PH1) in Children

GGC Paediatric Renal
NHS GGC

This document provides information on the Standard Operating Procedures (SOP) for the treatment of children with PH1 with lumasiran.
This document is intended for use by all health professionals (for example, doctors, nurses, dietitians and pharmacists) who look after children receiving lumasiran.

Resources

Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 02/01/2022

Next review date: 02/01/2023

Author(s): Mrs Angela Lamb, Dr Douglas Stewart.

Author email(s): angela.lamb@ggc.scot.nhs.uk, douglas.stewart@ggc.scot.nhs.uk.